Skip to main content

Neurocognitive Disorders in Older Adults (Vascular Dementia)

  • Chapter
  • First Online:
Primary Care Mental Health in Older People

Abstract

Recent developments in the understanding of the relationship between vascular risk factors, vascular cognitive disorders and dementia have led to a renewed interest in these risk factors and their management. The role of the primary care physician in the prevention, control and management of all aspects of vascular diseases is highlighted. Diagnostic criteria in the DSM, ICD and VASCOG systems are examined, in particular their relevance and usefulness in primary care settings. Cognitive domains in a “bedside” testing schedule may be helpful for the primary care physician in their daily practice. Primary and secondary care for people with vascular cognitive disorders places the primary care physician in crucial roles.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1993.

    Google Scholar 

  2. World Health Organization. The ICD-10 classification of mental and behavioral disorders: diagnostic criteria for research. Geneva: World Health Organization; 1993.

    Google Scholar 

  3. Holstein M. Alzheimer’s disease and senile dementia, 1885–1920: an interpretive history of disease negotiation. J Aging Stud. 1997;11:1–13.

    Article  Google Scholar 

  4. Hachinski VC, Lassen NA, Marshall J. Multi-infarct dementia: a cause of mental deterioration in the elderly. Lancet. 1974;2:207–10.

    Article  CAS  Google Scholar 

  5. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250–60.

    Article  CAS  Google Scholar 

  6. Hachinski VC, Iliff LD, Zilhka A, et al. Cerebral blood flow in dementia. Arch Neurol. 1975;32:632–7.

    Article  CAS  Google Scholar 

  7. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed, Text Revision ed. Washington, DC: American Psychiatric Association; 2000.

    Google Scholar 

  8. Chui HC, Mack W, Jackson JF, et al. Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and inter-rater reliability. Arch Neurol. 2000;57:191–6.

    Article  CAS  Google Scholar 

  9. Chui HC, Zarrow C, Mack WJ, et al. Cognitive impact of subcortical vascular and Alzheimer’s disease pathology. Ann Neurol. 2006;60:677–87.

    Article  Google Scholar 

  10. Sachdev P, Kalaria R, O’Brien J, et al. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014;28(3):206–18.

    Article  CAS  Google Scholar 

  11. Hachinski VC, Iadecola C, Peterson RC, et al. National Institute of Neurological disorders and Stroke - Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37:2220–41.

    Article  Google Scholar 

  12. Looi JCL, Sachdev PS. Differentiation of vascular dementia from AD on neuropsychological tests. Neurology. 1999;53:670–8.

    Article  CAS  Google Scholar 

  13. Barber R, Scheltens P, Gholkar A, et al. White matter lesions on magnetic resonance imaging in dementia with Lewy Bodies, Alzheimer’s disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry. 1999;67:66–72.

    Article  CAS  Google Scholar 

  14. Knopman DS, Parisi JE, Boeve BF, et al. Vascular dementia in a population based autopsy study. Arch Neurol. 2003;60:569–73.

    Article  Google Scholar 

  15. Hankey GJ. Clinical update: Management of stroke. Lancet. 2007;369:1330–2.

    Article  Google Scholar 

  16. Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer’s disease. The Nun Study. J Am Med Assoc. 1997;277:813–7.

    Article  CAS  Google Scholar 

  17. Heyman A, Fillenbaum G, Welsh-Bohmer KA, et al. Cerebral infarcts in patients with autopsy- proven Alzheimer’s disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer’s disease. Neurology. 1998;51:159–62.

    Article  CAS  Google Scholar 

  18. Goldstein L. Primary prevention of ischaemic stroke: a guideline. Stroke. 2006;37:1583–633.

    Article  Google Scholar 

  19. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke. 2006;37:577–617.

    Article  Google Scholar 

  20. Erkinjuntti T. Diagnosis and management of vascular cognitive impairment and dementia. J Neural Transm Suppl. 2002;63:91–109.

    Google Scholar 

  21. McShane R, Areosa Sastre A, Minakaran N. Memantine for dementia. Cochrane Database Syst Rev. 2006;(2):CD003154. https://doi.org/10.1002/14651858.

  22. Orgogozo J, Riguad A, Stoffler A, et al. Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM300). Stroke. 2002;33:1834–9.

    Article  CAS  Google Scholar 

  23. Wenzel C, Rockwood K, MacKnight C, et al. Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology. 2001;57:714–6.

    Article  Google Scholar 

  24. Meyer JS, Xu G, Thornby J, et al. Is mild cognitive impairment prodromal for vascular dementia like Alzheimer’s disease? Stroke. 2002;33:1981–5.

    Article  Google Scholar 

  25. Katzman R, Fox P. The world-wide impact of dementia. Projections of prevalence and costs. In: Mayeaux R, Christen Y, editors. Epidemiology of Alzheimer’s Disease: from gene to prevention. Berlin: Springer; 1999. p. 1–17.

    Google Scholar 

  26. Kirkman AM. Dementia in the news: the media coverage of Alzheimer’s disease. Australas J Ageing. 2006;25(2):74–9.

    Article  Google Scholar 

  27. Peel E. The living death of Alzheimer’s versus ‘Take a walk to keep dementia at bay’: representations of dementia in print media and career discourse. Sociol Health Illn. 2014;36:6. https://doi.org/10.1111/1.9566.12122.

    Article  Google Scholar 

  28. Behuniak SM. The living dead? The construction of people with Alzheimer’s disease as zombies. Ageing Soc. 2011;31(1):70–92.

    Article  Google Scholar 

  29. Burgener SC, Buckwalter KC. Examining perceived stigma in persons with dementia. Iowa: US Department of Health and Human Services, National Institute of Health; 2008.

    Google Scholar 

  30. Riley RI, Burgener S, Buckwalter KC. Anxiety and stigma in dementia: a threat to aging in place. Nurs Clin North Am. 2014;49(2):213–31.

    Article  Google Scholar 

  31. Kertez A, Davidson W, Fox H. Frontal behavioural inventory: diagnostic criteria for frontal lobe dementia. Can J Neurol Sci. 1997;24:29–36.

    Article  Google Scholar 

  32. Folstein MF, Folstein SE, McHugh PH. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.

    Article  CAS  Google Scholar 

  33. Osterweil D, Beck JC, Brummel-Smith K, editors. Comprehensive geriatric assessment. Castle Rock, Pittsford: McGraw-Hill Professional; 2000.

    Google Scholar 

  34. Agrell B, Review DO. The clock-drawing test. Age Ageing. 1998;27:399–403.

    Article  Google Scholar 

  35. Inouye SK, Robinson JT, Froelich TE, Richardson ED. The time and change test: a simple screening test for dementia. J Gerontol. 1998;53:M281–6.

    Article  CAS  Google Scholar 

  36. Borson S, Scanlan JM, Chen P, Ganguli M. The Mini-Cog as a screen for dementia: validation in a population-based sample. J Am Geriatr Soc. 2003;51:1451–4.

    Article  Google Scholar 

  37. Brodaty H, Pond D, Draper B, et al. Assisting general practitioners to screen for cognitive impairment: The General Practitioner Assessment of Cognition website. Alzheimers Dement. 2009;5(5):e15–6.

    Article  Google Scholar 

  38. LoGuidice D, Smith K, Thomas J, et al. Kimberly Indigenous Cognitive Assessment tool (KICA): development of a cognitive assessment tool for older indigenous Australians. Int Psychogeriatr. 2006;18(2):269–80.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edmond Chiu .

Editor information

Editors and Affiliations

Appendix

Appendix

Suggested “bedside” testing of cognitive domains listed above.

For frontal dysexecutive testing, the Frontal Behavioural Inventory (FBI) provides a useful schedule of 24 items which can be used in primary care setting [31].

1.1 Screening Inventories

Numerous assessments exist, and many brief assessments have been developed which are easy to administer and score. An important aim of using these screening instruments is to pick up cases of dementia as early as possible, since studies have shown that more than 50% of cases of dementia, most especially the mild to moderate ones, are missed by clinicians during routine clinical evaluation. They are simple to administer and require little time to do so.

  • Mini-Mental State Examination (MMSE) [31, 32]: Developed in 1975, with several modifications released since, the MMSE is the most widely known and researched screening tool. It is divided into two sections and takes 10–15 min to administer. Research indicates that it has satisfactory reliability and validity. It covers six areas of cognitive functioning: orientation, immediate recall, attention and calculation, language (including following verbal and written instructions and writing a spontaneous sentence) and copying interlocking pentagons. MMSE scores in the moderately impaired range can indicate either cognitive impairment associated with depression or an independent cognitive disorder [33].

  • Clock-Drawing Test (CDT): CDT tests memory, adaptive functioning, information processing and visual-spatial and executive functioning. A person is asked to draw a clock face (with or without a pre-drawn circle) and indicate a specified time. The more distorted and inaccurate the drawings are, the more likely the person has dementia [34].

  • Time and Change Test: This tests comprehension, working (or task completion) memory and planning and calculating skills. A person is given 60 s and two attempts to read the time on a clock and then is given 3 min and two attempts to make change for a dollar with three quarters, seven dimes and seven nickels [35]. Word recall: A person without memory problems should be able to remember at least three unrelated words and be able to recite them back after interruption with a distracting task. Someone who cannot remember at least two words out of three may have cognitive impairment. Another test is to ask a person to name as many items as possible in a given category, such as fruits or animals. Naming fewer than ten items in 1 min suggests slowed mental functioning [35].

  • Mini-Cognitive Assessment Instrument (Mini-Cog): This test has been proven to assess a person’s registration, recall and executive function and be effective culturally and educationally [36].

  • General Practitioner Assessment of Cognition (GPCOG): This tool, developed in 2002, is used for screening cognitive impairment in the primary care setting. The GPCOG includes a 4-min patient assessment and a 2-min caregiver interview. A web-based tool is available. Research has shown it to perform at least as well as the MMSE [37].

Note: Most of these instruments are standardized screening tools for dementia in accordance with internationally recognized guidelines. It should however be noted that clinicians and researchers in multi-ethnic and diverse cultural societies in Asia and Africa have customized few of these screening tools to the culture, language and literacy level of their local populations, such as “Test of Senegal,” developed for sub-Saharan African population. Other examples of such customized screening inventories are from the Indianapolis-Ibadan Dementia Project (IIDP) domiciled in Ibadan, Nigeria, that is, “Clinical Home-based Interview to assess Function” (CHIF), which measures activities of daily life drawing out statements from existing standard questionnaires, and “stick design”, a questionnaire that measures visuo-constructional abilities. For indigenous Australians, the Kimberley Indigenous Cognitive Assessment (KICA) tool [38] has been well validated for this population.

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Aina, O., Downes-Brydon, J., Chiu, E. (2019). Neurocognitive Disorders in Older Adults (Vascular Dementia). In: de Mendonça Lima, C., Ivbijaro, G. (eds) Primary Care Mental Health in Older People. Springer, Cham. https://doi.org/10.1007/978-3-030-10814-4_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-10814-4_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-10812-0

  • Online ISBN: 978-3-030-10814-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics